Wuxi Biologics Stock Analysis

WuXi Pink Sheet Analysis Notes

About 14.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.8. WuXi Biologics had not issued any dividends in recent years. The entity had 3:1 split on the 10th of December 2020. WuXi Biologics Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the Peoples Republic of China, North America, Europe, and internationally. The company was incorporated in 2014 and is headquartered in Wuxi, China. Wuxi Biologics is traded on OTC Exchange in the United States.The quote for WuXi Biologics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Zhisheng Chen at 86 510 8183 1205 or visit https://www.wuxibiologics.com.

WuXi Biologics Investment Alerts

WuXi Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 34.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate WuXi Biologics's market, we take the total number of its shares issued and multiply it by WuXi Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

WuXi Profitablity

The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.31 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.31.

Technical Drivers

As of the 2nd of December, WuXi Biologics maintains the Market Risk Adjusted Performance of 1.39, standard deviation of 6.07, and Mean Deviation of 2.13. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of WuXi Biologics, as well as the relationship between them. Please check out WuXi Biologics standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if WuXi Biologics is priced fairly, providing market reflects its latest price of 1.86 per share. Please also validate WuXi Biologics information ratio, which is currently at 0.0784 to confirm the company can sustain itself at a future point.

WuXi Biologics Price Movement Analysis

WuXi Biologics Outstanding Bonds

WuXi Biologics Predictive Daily Indicators

WuXi Biologics Forecast Models

WuXi Biologics' time-series forecasting models are one of many WuXi Biologics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary WuXi Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how WuXi Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling WuXi shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as WuXi Biologics. By using and applying WuXi Pink Sheet analysis, traders can create a robust methodology for identifying WuXi entry and exit points for their positions.

When running WuXi Biologics' price analysis, check to measure WuXi Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WuXi Biologics is operating at the current time. Most of WuXi Biologics' value examination focuses on studying past and present price action to predict the probability of WuXi Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WuXi Biologics' price. Additionally, you may evaluate how the addition of WuXi Biologics to your portfolios can decrease your overall portfolio volatility.